KMB vs NEPH · P/E 19, rev $8.35B vs P/E 48, rev $14.2M
Kimberly-Clark Corporation (KMB) versus Nephros Inc (NEPH) — a side-by-side from cached financials, not a winner call.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
Latest reported KMB revenue for 2026-06-30 was $8.35B. Net income was $1.01B. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
Latest reported NEPH revenue for 2024-12-31 was $14.2M. Net income was $74.0K. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
KMB currently screens at market cap $32.88B and trailing P/E 19.2. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Not investment advice. Open the KMB and NEPH stock pages for the full models.
Not investment advice.